top of page
it's where dermatology lives



Potential vaccine targets identified for pediatric AD
New research suggests a “tailored vaccine” might hold the key to treating bacteria-driven atopic dermatitis (AD) flares in children....
John Evans
May 10, 20243 min read


VIDEO: Depression, suicidal ideation low in PsO patients on bimekizumab, according to new study
Suicidal ideation and behaviour and depression are low and within general psoriasis ranges in patients being treated with bimekizumab.
Jeremy Visser
May 8, 20241 min read


Neuropeptide in blood may lead to targeted treatment for chronic itch
A new study has identified what may be the first biomarker for chronic itch. Published in Drugs in Dermatology, researchers from the...
Allan Ryan
May 6, 20242 min read


U.S. FDA issues counterfeit botulinum toxin alert
The U.S. Food and Drug Administration (FDA) has released an alert to healthcare professionals and consumers that unsafe counterfeit versions
John Evans
May 3, 20242 min read


VIDEO: New study highlights delays in diagnosis for HS
There are significant delays in diagnosis and low implementation rates for treatment for HS.
Jeremy Visser
May 1, 20241 min read


Melanoma vaccine enters international trial phase
Phase III studies of a personalized vaccine plus immunotherapy for melanoma have been launched at cancer centres around the world,...
Allan Ryan
Apr 29, 20242 min read


Identified: Porokeratosis variant caused by silenced gene
“We thus expect that epigenetic causes are hidden not only in these but also in other diseases"
John Evans
Apr 26, 20243 min read


VIDEO: Topical melatonin, rosuvastatin may reduce severity of mild-to-moderate plaque PsO
Topical melatonin and topical rosuvastatin were both effective in reducing the severity of mild-to-moderate plaque PsO.
Jeremy Visser
Apr 24, 20241 min read
Featured Posts




bottom of page

